The Cigna Group (NYSE:CI) Shares Bought by Vaughan David Investments LLC IL

Vaughan David Investments LLC IL boosted its holdings in shares of The Cigna Group (NYSE:CI) by 1.7% in the fourth quarter, HoldingsChannel reports. The firm owned 144,147 shares of the health services provider’s stock after buying an additional 2,370 shares during the period. Vaughan David Investments LLC IL’s holdings in The Cigna Group were worth $39,805,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Prospera Private Wealth LLC acquired a new position in shares of The Cigna Group in the third quarter worth about $37,000. Collier Financial acquired a new position in shares of The Cigna Group in the fourth quarter worth about $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group in the fourth quarter worth about $34,000. Harbor Capital Advisors Inc. acquired a new position in shares of The Cigna Group in the third quarter worth about $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group in the fourth quarter worth about $37,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Price Performance

Shares of CI opened at $300.80 on Tuesday. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The firm’s fifty day simple moving average is $286.90 and its 200-day simple moving average is $319.23. The firm has a market capitalization of $83.67 billion, a price-to-earnings ratio of 24.58, a PEG ratio of 0.98 and a beta of 0.54. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the business earned $6.79 EPS. Equities analysts forecast that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 2.01%. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.

Analysts Set New Price Targets

CI has been the subject of a number of analyst reports. Morgan Stanley decreased their price objective on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Barclays cut their target price on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Raymond James reissued a “strong-buy” rating and set a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Truist Financial dropped their price objective on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research note on Tuesday, February 4th. Finally, UBS Group dropped their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.